What are the effects of Oseltamivir Granules?
Jan 21, 2025
Source: Cainiu Health
Dr. Ren Yi
Introduction
Oseltamivir granules refer to oseltamivir phosphate granules. Generally, oseltamivir phosphate granules are indicated for the treatment of influenza A, treatment of influenza B, prevention of influenza A, prevention of influenza B, and reduction of the risk of influenza complications. Patients are advised to strictly follow medical instructions when taking this medication, avoiding self-medication or abrupt discontinuation of the drug, in order to ensure safe and effective use.
Osetamivir granules refer to oseltamivir phosphate granules. Generally, oseltamivir phosphate granules have the following functions: treating type A influenza, treating type B influenza, preventing type A influenza, preventing type B influenza, and reducing the risk of influenza complications. The details are as follows:
1. Treatment of type A influenza: Oseltamivir phosphate granules can inhibit the neuraminidase on the surface of the type A influenza virus, preventing the release of progeny virus from infected cells, thereby reducing further viral spread within the body. This alleviates the severity of symptoms such as fever, headache, and muscle pain, and helps shorten the duration of illness.
2. Treatment of type B influenza: Oseltamivir phosphate granules are also effective against the type B influenza virus, with a mechanism of action targeting the virus's neuraminidase. After infection with type B influenza, timely administration of oseltamivir phosphate granules can inhibit viral release and spread.
3. Prevention of type A influenza: For individuals who have had contact with someone infected with type A influenza, starting treatment with oseltamivir phosphate granules within 48 hours of exposure can reduce the risk of infection.
4. Prevention of type B influenza: Similar to the prevention of type A influenza, oseltamivir phosphate granules can also provide protective effects after exposure to type B influenza, helping to prevent infection with the type B influenza virus.
5. Reduction of influenza complication risks: Untreated or delayed treatment of type A or B influenza may lead to complications such as pneumonia, myocarditis, and encephalitis. Oseltamivir phosphate granules inhibit the replication and spread of the influenza virus, thereby reducing damage to various organs and lowering the likelihood of these severe complications.
Patients are advised to strictly follow medical instructions for medication in daily use, avoiding self-medication or abrupt discontinuation of treatment to ensure drug safety and efficacy.
